Showing 1 - 2 results of 2 for search 'William Rigby', query time: 0.01s Refine Results
  1. 1
    Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.

    Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program. by Paul Emery, William Rigby, Paul P Tak, Thomas Dörner, Ewa Olech, Carmen Martin, Laurie Millar, Helen Travers, Elena Fisheleva

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study

    Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study by Josef S Smolen, Yoshiya Tanaka, Paul Emery, Manish Jain, Koji Kato, Stanley B Cohen, Nasser Khan, William Rigby, Sebastian Meerwein, Juan Ignacio Vargas, Kyle M Carter, Charles Phillips

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: